Universal Ibogaine Inc.
IBOGF · OTC
7/31/2022 | 7/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $7 | $12 | $1 | $1 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $8 | $12 | $1 | $1 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$5 | -$4 | $0 | -$0 |
| % Margin | -430.3% | – | – | – |
| Net Income | -$10 | -$4 | -$0 | -$0 |
| % Margin | -980.2% | – | – | – |
| EPS Diluted | -0.057 | -0.031 | -0.01 | -0.01 |
| % Growth | -82.8% | -209% | 0% | – |
| Operating Cash Flow | -$4 | -$3 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$4 | -$3 | -$0 | -$0 |